NYSE:MDT - Medtronic Stock Price, News, & Analysis

Medtronic trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDT."

Medtronic announced a quarterly dividend on Friday, December 7th. Investors of record on Friday, December 28th will be given a dividend of $0.50 per share on Friday, January 18th. This represents a $2.00 annualized dividend and a yield of 2.09%. The ex-dividend date is Thursday, December 27th. View Medtronic's Dividend History.

Medtronic declared that its board has approved a stock repurchase program on Thursday, October 5th 2017, which authorizes the company to repurchase $5,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase up to 49% of its stock through open market purchases. Stock repurchase programs are typically an indication that the company's board of directors believes its shares are undervalued.

Medtronic PLC (NYSE:MDT) posted its earnings results on Tuesday, November, 20th. The medical technology company reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.15 by $0.07. The medical technology company had revenue of $7.48 billion for the quarter, compared to analyst estimates of $7.35 billion. Medtronic had a return on equity of 13.51% and a net margin of 7.44%. The firm's revenue was up 6.1% on a year-over-year basis. During the same period in the previous year, the firm earned $1.07 earnings per share. View Medtronic's Earnings History.

Medtronic is scheduled to release their next quarterly earnings announcement on Tuesday, February 19th 2019. View Earnings Estimates for Medtronic.

Medtronic issued an update on its third quarter earnings guidance on Tuesday, November, 20th. The company provided EPS guidance of $1.23-1.25 for the period. Medtronic also updated its FY 2019 guidance to $5.10-5.15 EPS.

19 equities research analysts have issued 1-year price objectives for Medtronic's shares. Their forecasts range from $88.00 to $120.00. On average, they anticipate Medtronic's share price to reach $104.8611 in the next twelve months. This suggests a possible upside of 9.6% from the stock's current price. View Analyst Price Targets for Medtronic.

19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medtronic in the last year. There are currently 6 hold ratings, 12 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Medtronic.

Media headlines about MDT stock have been trending somewhat positive on Wednesday, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Medtronic earned a coverage optimism score of 1.0 on InfoTrie's scale. They also gave media coverage about the medical technology company a news buzz of 4.0 out of 10, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.

Some companies that are related to Medtronic include Varian Medical Systems (VAR), SONOVA HLDG AG/ADR (SONVY), Masimo (MASI), LivaNova (LIVN), GETINGE AB/ADR (GNGBY), NxStage Medical (NXTM), CONMED (CNMD), AxoGen (AXGN), Natus Medical (BABY), Viewray (VRAY), Cutera (CUTR), BioLife Solutions (BLFS), Semler Scientific (SMLR), Rockwell Medical (RMTI) and Electrocore (ECOR).

Medtronic's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (8.10%), BlackRock Inc. (7.21%), Massachusetts Financial Services Co. MA (4.25%), Franklin Resources Inc. (2.08%), Dodge & Cox (1.31%) and Bank of New York Mellon Corp (1.26%). Company insiders that own Medtronic stock include Bradley E Lerman, Bryan C Hanson, Carol A Surface, Geoffrey Martha, Hoedt Rob Ten, Hooman Hakami, James T Lenehan, Michael J Coyle, Omar Ishrak, Richard H Anderson, Richard Kuntz and Robert C Pozen. View Institutional Ownership Trends for Medtronic.

MDT stock was sold by a variety of institutional investors in the last quarter, including Franklin Resources Inc., Capital Research Global Investors, Mitsubishi UFJ Trust & Banking Corp, The Manufacturers Life Insurance Company, Sanders Capital LLC, Dodge & Cox, Massachusetts Financial Services Co. MA and Wells Fargo & Company MN. Company insiders that have sold Medtronic company stock in the last year include Bradley E Lerman, Bryan C Hanson, Carol A Surface, Geoffrey Martha, Hooman Hakami, James T Lenehan, Michael J Coyle and Richard Kuntz. View Insider Buying and Selling for Medtronic.

MDT stock was bought by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Nordea Investment Management AB, Pendal Group Ltd, Renaissance Technologies LLC, Man Group plc, American Century Companies Inc., FMR LLC and Marshall Wace North America L.P.. Company insiders that have bought Medtronic stock in the last two years include Richard H Anderson and Robert C Pozen. View Insider Buying and Selling for Medtronic.

Shares of MDT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MDT stock can currently be purchased for approximately $95.71.

Medtronic has a market capitalization of $126.57 billion and generates $29.95 billion in revenue each year. The medical technology company earns $3.10 billion in net income (profit) each year or $4.77 on an earnings per share basis. Medtronic employs 86,000 workers across the globe.

The official website for Medtronic is http://www.medtronic.com.

Medtronic's mailing address is 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02. The medical technology company can be reached via phone at 353-1438-1700 or via email at [email protected]